These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 3926905)

  • 1. Analysis of tyrosinases as asparagin-linked oligosaccharides by concanavalin A lectin chromatography: appearance of new segment of tyrosinases in melanoma cells following interrupted melanogenesis induced by glycosylation inhibitors.
    Imokawa G; Mishima Y
    J Invest Dermatol; 1985 Aug; 85(2):165-8. PubMed ID: 3926905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors.
    Imokawa G; Mishima Y
    J Invest Dermatol; 1984 Sep; 83(3):196-201. PubMed ID: 6432920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of carbohydrate properties essential for melanogenesis in tyrosinases of cultured malignant melanoma cells by differential carbohydrate processing inhibition.
    Imokawa G
    J Invest Dermatol; 1990 Jul; 95(1):39-49. PubMed ID: 2114451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.
    Imokawa G; Mishima Y
    Cancer Res; 1982 May; 42(5):1994-2002. PubMed ID: 6802485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of glycoproteins in the initiation of melanogenesis: an electron microscopic study of B-16 melanoma cells after release from inhibition of glycosylation.
    Imokawa G; Mishima Y
    J Invest Dermatol; 1986 Sep; 87(3):319-25. PubMed ID: 3734483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione.
    Imokawa G
    J Invest Dermatol; 1989 Jul; 93(1):100-7. PubMed ID: 2501395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of hamster melanoma tyrosinases and structural studies of their asparagine-linked sugar chains.
    Ohkura T; Yamashita K; Mishima Y; Kobata A
    Arch Biochem Biophys; 1984 Nov; 235(1):63-77. PubMed ID: 6437339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
    Iwata K; Takeuchi T
    J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tyrosinases of the pigmented portions of the eye in 4 species of rodent].
    Voulot C; Laviolette P
    C R Acad Hebd Seances Acad Sci D; 1976 Jul; 283(1):79-81. PubMed ID: 827352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of mouse tyrosinase by enzyme-linked immunosorbent assay.
    Ishiguro S; Yamamoto H; Yanai N; Takeuchi T
    J Biochem; 1986 Apr; 99(4):1081-5. PubMed ID: 3086301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-lives of tyrosinase isozymes from Harding-Passey mouse melanoma.
    Martinez JH; Solano F; PeƱafiel R; Lozano JA
    Cancer Lett; 1988 Jan; 38(3):339-46. PubMed ID: 3127037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of melanogenesis by glycosylation inhibitors and the inhibitory effect of interferon on melanoma metastasis].
    Mishima Y; Ueda M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1235-44. PubMed ID: 2408578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
    Tomita Y; Moro S; Seiji M
    J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
    Imokawa G; Mishima Y
    Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
    Jimbow K; Jimbow M; Chiba M
    J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective aberration and pigment loss in melanosomes of malignant melanoma cells in vitro by glycosylation inhibitors: premelanosomes as glycoprotein.
    Mishima Y; Imokawa G
    J Invest Dermatol; 1983 Aug; 81(2):106-14. PubMed ID: 6409969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
    Mojamdar M; Imokawa G; Mishima Y
    J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical characterization of tyrosinase inhibitors using tyrosinase binding affinity chromatography.
    Imokawa G; Mishima Y
    Br J Dermatol; 1981 May; 104(5):531-9. PubMed ID: 6786320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Active tyrosinase site in melanin synthesizing cells; biochemical study of GERL (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Mar; 88(4):275-87. PubMed ID: 97423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.